[1] Yuan Z, Lu Y, Wei J, et al.Abdominal Aortic Aneurysm: Roles of Inflammatory Cells[J]. Front Immunol, 2021, 11: 609161. [2] Nordon IM, Hinchliffe RJ, Loftus IM, et al.Pathophysiology and epidemiology of abdominal aortic aneurysms[J]. Nat Rev Cardiol, 2011, 8(2): 92-102. [3] Bossone E, Labounty TM, Eagle KA.Acute aortic syndromes: diagnosis and management, an update[J]. Eur Heart J, 2018, 39(9): 739-749d. [4] Sakalihasan N, Michel JB, Katsargyris A, et al.Abdominal aortic aneurysms[J]. Nat Rev Dis Primers, 2018, 4(1): 34. [5] Hinchliffe RJ, Bruijstens L, Macsweeney STR, et al. A randomised trial of endovascular and open surgery for ruptured abdominal aortic aneurysm - results of a pilot study and lessons learned for future studies [J]. Eur J Vasc Endovasc Surg, 2006, 32(5): 506-13; discussion 514-5. [6] Raffort J, Lareyre F, Clément M, et al.Monocytes and macrophages in abdominal aortic aneurysm[J]. Nat Rev Cardiol, 2017, 14(8): 457-471. [7] Chandel NS.Carbohydrate Metabolism[J]. Cold Spring Harb Perspect Biol, 2021, 13(1). [8] Tsuruda T, Hatakeyama K, Nagamachi S, et al.Inhibition of development of abdominal aortic aneurysm by glycolysis restriction[J]. Arterioscler Thromb Vasc Biol, 2012, 32(6): 1410-1417. [9] Luo C, Zhou B, Cui Y, et al.ALDH2 knockout protects against aortic dissection[J]. BMC Cardiovasc Disord, 2022, 22(1): 443. [10] Yang K, Ren J, Li X, et al.Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype[J]. Eur Heart J, 2020, 41(26): 2442-2453. [11] Mutch DM, Berger A, Mansourian R, et al.The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data[J]. BMC Bioinformatics, 2002, 3: 17. [12] Yang Y, Yang Y, Liu J, et al.Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia[J]. Front Immunol, 2022, 13: 1038570. [13] Ren J, Lv Y, Wu L, et al.Key ferroptosis-related genes in abdominal aortic aneurysm formation and rupture as determined by combining bioinformatics techniques[J]. Front Cardiovasc Med, 2022, 9: 875434. [14] Lai CH, Chang CW, Lee FT, et al.Targeting vascular smooth muscle cell dysfunction with xanthine derivative KMUP-3 inhibits abdominal aortic aneurysm in mice[J]. Atherosclerosis, 2020, 297: 16-24. [15] Wirka RC, Wagh D, Paik DT, et al.Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis[J]. Nat Med, 2019, 25(8): 1280-1289. [16] Xiong T, Lv XS, Wu GJ, et al.Single-Cell Sequencing Analysis and Multiple Machine Learning Methods Identified G0S2 and HPSE as Novel Biomarkers for Abdominal Aortic Aneurysm[J]. Front Immunol, 2022, 13: 907309. [17] Villéger R, Chulkina M, Mifflin RC, et al.Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer[J]. Br J Cancer, 2023, 128(4): 537-548. [18] Liu Q, Wang Q, Li H, et al.Embelin inhibits abdominal aortic aneurysm through decreasing IL-6-induced STAT3 and NF-κB inactivation[J]. Mol Med Rep, 2018, 18(2):2365-2372. [19] Jabłońska A, Zagrapan B, Neumayer C, et al.Polymorphisms in the IL-6 and TNF-α gene are associated with an increased risk of abdominal aortic aneurysm[J]. Int J Cardiol, 2021, 329: 192-197. [20] Tang W, Zhou Y, Zhao T, et al.Effect of interleukin-6 (IL-6) on the vascular smooth muscle contraction in abdominal aorta of rats with streptozotocin-induced diabetes[J]. Chin J Physiol, 2011, 54(5): 318-323. |